Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Advanced Medical Solutions GroupCHIX:AMSL 77 3-Year EPS without NRI Growth Rate is 3.70% as of Dec. 2025, which is 75% below its 10-year median of 14.75. GuruFocus rates CHIX:AMSL with a GF Score™ of 77/100 and a GF Value™ of £3.75 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 658 Medical Devices & Instruments companies, Advanced Medical Solutions Group ranks worse than 56.23% on this metric.
During the past 12 months, Advanced Medical Solutions Group's average EPS without NRI Growth Rate was 11.40% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 3.70% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 12.00% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 3.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Advanced Medical Solutions Group was 122.40% per year. The lowest was -23.30% per year. And the median was 14.75% per year.
Advanced Medical Solutions Group (CHIX:AMSl) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Advanced Medical Solutions Group 3-Year EPS without NRI Growth Rate Related Terms
CHIX:AMSL vs ISRG, BDX, MDLN: 3-Year EPS without NRI Growth Rate Comparison
For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Medical Solutions Group 3-Year EPS without NRI Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Advanced Medical Solutions Group's 3-Year EPS without NRI Growth Rate falls into.
Advanced Medical Solutions Group 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 3.70% mean?
Advanced Medical Solutions Group (CHIX:AMSL) has a 3-Year EPS without NRI Growth Rate of 3.70% as of Dec. 2025. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Advanced Medical Solutions Group and its competitors. This is 75% below median its historical median of 14.75. According to the industry distribution chart, Advanced Medical Solutions Group ranks #370 out of 658 companies in the Medical Devices & Instruments industry, placing it in the top 56.2%.
Is Advanced Medical Solutions Group's 3-Year EPS without NRI Growth Rate too high?
Advanced Medical Solutions Group's current 3-Year EPS without NRI Growth Rate of 3.70% is 75% below median its 10-year median of 14.75. The Medical Devices & Instruments industry median 3-Year EPS without NRI Growth Rate is 7.90. Advanced Medical Solutions Group's value of 3.70% is 53.2% below this industry median. Based on the distribution chart, Advanced Medical Solutions Group ranks #370 out of 658 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Advanced Medical Solutions Group has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Medical Solutions Group's 3-Year EPS without NRI Growth Rate compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Advanced Medical Solutions Group ranks #370 out of 658 companies for 3-Year EPS without NRI Growth Rate. This places Advanced Medical Solutions Group in the lower half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 7.90. Advanced Medical Solutions Group's value of 3.70% is 53.2% below this benchmark. While the company's 10-year median is 14.75 vs. the industry median of 7.90, Advanced Medical Solutions Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EPS without NRI Growth Rate among Medical Devices & Instruments companies is 7.90, based on 658 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Advanced Medical Solutions Group's current 3-Year EPS without NRI Growth Rate of 3.70% is 53.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Advanced Medical Solutions Group and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EPS without NRI Growth Rate is 7.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advanced Medical Solutions Group's current 3-Year EPS without NRI Growth Rate is 3.70%, which is 75% below median its own 10-year median of 14.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Medical Solutions Group stock overvalued right now?
Based on GuruFocus' analysis, Advanced Medical Solutions Group (CHIX:AMSL) is currently considered Modestly Undervalued. The stock's GF Value™ is £3.75, compared to a current price of £2.82 — trading 24.9% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 3.70%, which is 75% below median its 10-year median of 14.75 and 53.2% below the Medical Devices & Instruments industry median of 7.90. Advanced Medical Solutions Group's overall GF Score™ is 77/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Advanced Medical Solutions Group (CHIX:AMSL), the current 3-Year EPS without NRI Growth Rate is 3.70% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Advanced Medical Solutions Group (CHIX:AMSL) Overvalued in 2026?
Based on GuruFocus' analysis, Advanced Medical Solutions Group stock appears to be undervalued.
The current stock price of £2.82 is trading 24.9% below its estimated GF Value™ of £3.75.
GuruFocus considers Advanced Medical Solutions Group to be Modestly Undervalued.
Key valuation signals for CHIX:AMSL:
3-Year EPS without NRI Growth Rate: 3.70% (75% below median its 10-year median of 14.75)
GF Value™: £3.75 vs. price of £2.82 (24.9% below fair value)
Industry Position: 53.2% below the Medical Devices & Instruments median (#370 of 658)
No single metric tells the full story. See the CHIX:AMSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.
77GF Score
Get the complete analysis for CHIX:AMSL
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMSL has been successfully added to your 
